(LGCY) Legacy Education - Ratings and Ratios
Vocational, Nursing, Allied, Administrative, Programs
LGCY EPS (Earnings per Share)
LGCY Revenue
Description: LGCY Legacy Education
Legacy Education Inc. is a education services provider catering to students, recent high school graduates, and working parents across the United States, with a primary focus on healthcare and business-related vocational training. The companys diverse portfolio includes programs in medical imaging, nursing, dental assisting, and administrative specialties, among others. By offering a range of certificate and degree programs, Legacy Education Inc. aims to equip students with the skills required to succeed in their chosen fields.
Operating through six academic institutions in California, including High Desert Medical College, Central Coast College, Contra Costa Medical Career College, and Integrity College of Health, the company has established a strong regional presence. With its headquarters in Temecula, California, and incorporated in 2020, Legacy Education Inc. has quickly become a notable player in the education sector. The companys website (https://www.legacyed.com) provides further information on its programs and services.
From a technical analysis perspective, the stock has demonstrated a positive trend, with its last price of $9.08 exceeding both its 20-day and 50-day simple moving averages (SMA20 and SMA50) of $6.99 and $6.91, respectively. The stocks 200-day simple moving average (SMA200) is $7.10, indicating a longer-term uptrend. The average true range (ATR) is $0.46, representing a volatility of 5.06%. Given the current technical indicators and fundamental data, including a market capitalization of $106.82M USD and a price-to-earnings ratio of 16.62, it is likely that the stock will continue its upward trajectory, potentially reaching the 52-week high of $9.68 in the near term.
Based on the available
LGCY Stock Overview
| Market Cap in USD | 107m |
| Sub-Industry | Education Services |
| IPO / Inception | 2024-09-26 |
LGCY Stock Ratings
| Growth Rating | 59.9 |
| Fundamental | 75.4% |
| Dividend Rating | - |
| Rel. Strength | 145 |
| Analysts | 5.00 of 5 |
| Fair Price Momentum | 11.22 USD |
| Fair Price DCF | 1.34 USD |
LGCY Dividends
Currently no dividends paidLGCY Growth Ratios
| Growth Correlation 3m | 69.3% |
| Growth Correlation 12m | 71.2% |
| Growth Correlation 5y | 71.2% |
| CAGR 5y | 178.36% |
| CAGR/Max DD 5y | 4.92 |
| Sharpe Ratio 12m | 0.37 |
| Alpha | 162.84 |
| Beta | 0.833 |
| Volatility | 88.08% |
| Current Volume | 69.5k |
| Average Volume 20d | 71.8k |
| Stop Loss | 10.4 (-7.1%) |
| Signal | -1.35 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (19.2m TTM) > 0 and > 6% of Revenue (6% = 3.54m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -7.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.22% (prev 28.80%; Δ 8.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 3.74m <= Net Income 19.2m (YES >=105%, WARN >=100%) |
| Net Debt (209.1k) to EBITDA (9.17m) ratio: 0.02 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.65 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (9.82m) change vs 12m ago -64.66% (target <= -2.0% for YES) |
| Gross Margin 43.45% (prev 45.27%; Δ -1.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 119.1% (prev 134.1%; Δ -14.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 89.59 (EBITDA TTM 9.17m / Interest Expense TTM 98.9k) >= 6 (WARN >= 3) |
Altman Z'' 4.43
| (A) 0.33 = (Total Current Assets 35.3m - Total Current Liabilities 13.3m) / Total Assets 67.1m |
| (B) 0.19 = Retained Earnings (Balance) 12.5m / Total Assets 67.1m |
| (C) 0.18 = EBIT TTM 8.86m / Avg Total Assets 49.5m |
| (D) 0.45 = Book Value of Equity 12.5m / Total Liabilities 27.8m |
| Total Rating: 4.43 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.36
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 3.20% = 1.60 |
| 3. FCF Margin 5.05% = 1.26 |
| 4. Debt/Equity 0.09 = 2.50 |
| 5. Debt/Ebitda 0.37 = 2.39 |
| 6. ROIC - WACC 10.49% = 12.50 |
| 7. RoE 58.72% = 2.50 |
| 8. Rev. Trend 13.58% = 0.68 |
| 9. Rev. CAGR -16.16% = -2.50 |
| 10. EPS Trend 76.88% = 1.92 |
| 11. EPS CAGR 88.85% = 2.50 |
What is the price of LGCY shares?
Over the past week, the price has changed by +2.85%, over one month by -3.20%, over three months by +43.83% and over the past year by +178.36%.
Is Legacy Education a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LGCY is around 11.22 USD . This means that LGCY is currently overvalued and has a potential downside of 0.27%.
Is LGCY a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LGCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.7 | -4.8% |
| Analysts Target Price | 10.7 | -4.8% |
| ValueRay Target Price | 12.6 | 12.2% |
Last update: 2025-08-15 04:42
LGCY Fundamental Data Overview
CCE Cash And Equivalents = 17.3m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.6154
P/S = 2.026
P/B = 3.281
Beta = None
Revenue TTM = 59.0m USD
EBIT TTM = 8.86m USD
EBITDA TTM = 9.17m USD
Long Term Debt = 106.9k USD (from longTermDebt, last quarter)
Short Term Debt = 3.29m USD (from shortTermDebt, last quarter)
Debt = 3.40m USD (Calculated: Short Term 3.29m + Long Term 106.9k)
Net Debt = 209.1k USD (from netDebt column, last quarter)
Enterprise Value = 92.9m USD (106.8m + Debt 3.40m - CCE 17.3m)
Interest Coverage Ratio = 89.59 (Ebit TTM 8.86m / Interest Expense TTM 98.9k)
FCF Yield = 3.20% (FCF TTM 2.98m / Enterprise Value 92.9m)
FCF Margin = 5.05% (FCF TTM 2.98m / Revenue TTM 59.0m)
Net Margin = 32.53% (Net Income TTM 19.2m / Revenue TTM 59.0m)
Gross Margin = 43.45% ((Revenue TTM 59.0m - Cost of Revenue TTM 33.3m) / Revenue TTM)
Tobins Q-Ratio = 7.41 (Enterprise Value 92.9m / Book Value Of Equity 12.5m)
Interest Expense / Debt = 0.78% (Interest Expense 26.3k / Debt 3.40m)
Taxrate = 26.78% (from yearly Income Tax Expense: 1.87m / 6.99m)
NOPAT = 6.49m (EBIT 8.86m * (1 - 26.78%))
Current Ratio = 2.65 (Total Current Assets 35.3m / Total Current Liabilities 13.3m)
Debt / Equity = 0.09 (Debt 3.40m / last Quarter total Stockholder Equity 39.3m)
Debt / EBITDA = 0.37 (Net Debt 209.1k / EBITDA 9.17m)
Debt / FCF = 1.14 (Debt 3.40m / FCF TTM 2.98m)
Total Stockholder Equity = 32.7m (last 4 quarters mean)
RoA = 28.59% (Net Income 19.2m, Total Assets 67.1m )
RoE = 58.72% (Net Income TTM 19.2m / Total Stockholder Equity 32.7m)
RoCE = 27.03% (Ebit 8.86m / (Equity 32.7m + L.T.Debt 106.9k))
RoIC = 19.31% (NOPAT 6.49m / Invested Capital 33.6m)
WACC = 8.82% (E(106.8m)/V(110.2m) * Re(9.08%)) + (D(3.40m)/V(110.2m) * Rd(0.78%) * (1-Tc(0.27)))
Shares Correlation 5-Years: -94.90 | Cagr: -30.62%
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 66.10% ; FCFE base≈3.26m ; Y1≈2.16m ; Y5≈1.00m
Fair Price DCF = 1.34 (DCF Value 16.6m / Shares Outstanding 12.4m; 5y FCF grow -39.44% → 3.0% )
Revenue Correlation: 13.58 | Revenue CAGR: -16.16%
Revenue Growth Correlation: 69.12%
EPS Correlation: 76.88 | EPS CAGR: 88.85%
EPS Growth Correlation: 26.09%
Additional Sources for LGCY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle